AME

Business profile & competitive position

AMETEK, Inc. is a global manufacturer of electronic instruments and electromechanical devices, operating through two reportable groups. The Electronic Instruments Group (EIG) designs and manufactures advanced analytical, test and measurement instruments for process, aerospace, power and industrial markets. The Electromechanical Group (EMG) supplies precision motion control solutions, highly engineered medical components and devices, thermal management systems, specialty metals and electrical interconnects to aerospace and defense, medical, automation and other industrial markets. The company is classified in the Industrials sector under the Electrical Equipment & Parts industry.

The latest financial posture shows a 20.0% net margin and a 14.5% return on equity. Those are double-digit profitability and mid-teens equity returns, which are consistent with a business that can price specialized products and manage costs. They do not, by themselves, prove a deep competitive moat, but they do indicate that AMETEK has translated its engineering-heavy product mix into bottom-line performance. With a market capitalization of $55.9 billion and a beta of 0.96, the stock behaves roughly in line with the broader market, fitting its profile as a large, diversified industrial.

Financial posture

AMETEK currently trades at a P/E ratio of 35.5 and carries a $55.9 billion market cap. A multiple in the mid-30s is well above the range typical of cyclical, capital-goods-heavy industrials, so the valuation appears to bake in above-average growth and execution reliability. That reading is reinforced by the company’s 2025 results: sales of $7,401.1 million, up 6.6% from 2024, and diluted earnings per share of $6.40, up 7.9%. Management also described 2025 as producing record operating income, net income, orders and backlog.

The 20.0% net margin and 14.5% ROE back up the premium rating to the extent that they show consistent conversion of revenue into profit and equity returns. At the same time, the company is an active acquirer: in 2025 alone it deployed $933.2 million in cash, net of cash acquired, to buy Kern and FARO Technologies to add high-precision machining, optical inspection and 3D measurement capabilities. The balance sheet therefore needs to be watched for acquisition-related cash deployment, even though no specific debt or leverage figures were supplied in the current data set.

Strategic priorities & outlook

AMETEK’s most recent 10-K filing outlines a clear operational blueprint. The company is pursuing what it calls the AMETEK Growth Model, which targets high-single-digit annual sales growth, double-digit annual EPS growth, strong cash flow generation, and a superior return on total capital. Those are quantitative goals that investors can track directly against the 2025 outcome of 6.6% sales growth and 7.9% EPS growth.

Operationally, the company emphasizes lean manufacturing, global sourcing, Design for Six Sigma, Value Engineering/Value Analysis, growth kaizens, digitalization and artificial intelligence. Those initiatives are aimed at margin protection rather than top-line expansion alone. On growth, AMETEK relies heavily on acquisitions: it completed 15 acquisitions from 2021 through December 31, 2025, contributing roughly $1.8 billion in annualized sales. The 2025 deals for Kern and FARO are examples of the strategy in action, adding adjacent measurement and imaging technologies.

Geographic diversification is also a stated priority. The company maintains best-cost manufacturing facilities in China, Czechia, Malaysia, Mexico and Serbia for customer proximity and international growth. In 2025, 52% of EIG’s net sales and 42% of EMG’s net sales went to customers outside the United States. As of December 31, 2025, AMETEK employed approximately 22,500 people.

Macro & geopolitical exposure

Because AMETEK sits in the Industrials sector and specifically in Electrical Equipment & Parts, the business is exposed to broad manufacturing capital spending, aerospace and defense budgets, medical device demand, power and industrial automation cycles, and aftermarket spending on measurement and control equipment. Those end markets are cyclical and sensitive to corporate capex decisions, interest rates and government procurement.

Supply-chain inputs matter as well. Products rely on semiconductors, specialty metals, electrical interconnects and precision-machined components, so availability and pricing of those inputs can affect margins. With roughly half of segment sales outside the U.S. and manufacturing footprints in China, Czechia, Malaysia, Mexico and Serbia, the company is also exposed to currency translation and to trade policy, including tariffs and any restrictions on cross-border shipments. Regulatory exposure is inherent to the industries it serves: medical device approvals, aerospace certification, defense export controls, environmental rules and product safety standards can all affect time to market and cost structure. Energy costs and commodity prices can additionally influence both input costs and customer demand in certain industrial end markets.

Recent developments

Recent headlines have centered on institutional accumulation and the upcoming third-quarter 2026 report. On October 15, 2026, Zacks.com published “Is AMETEK (AME) Outperforming Other Computer and Technology Stocks This Year?” It is worth noting that AMETEK is classified under Industrials/Electrical Equipment & Parts rather than technology, so the article’s grouping is a classification choice by the publisher. The same day, PR Newswire reported that AMETEK announced its third-quarter 2026 earnings call and webcasted investor conference call information.

Also on October 15, 2026, Defense World reported that Krilogy Financial LLC purchased AMETEK shares, while on October 9, 2026, it reported that GAMMA Investing LLC bought AMETEK stock. These filings show recent institutional interest, though they do not indicate whether the stock is attractively priced today. The next scheduled earnings date is November 3, 2026, before the market open, with a consensus EPS estimate of $2.11. In the snapshot accompanying the data, AMETEK was trading at $243.83, with an RSI of 46.6 and a 50-day EMA of $244.57, effectively parked at its short-term moving average.

Earnings behavior & post-earnings drift

AMETEK has an unusually consistent earnings record. Over the last eight reported quarters, the company beat estimates every time, for a 100% beat rate, with an average earnings surprise of 4%. Despite the reliability of the beats, the average five-day price move after earnings has been just 0.46%, classified as flat. That combination tells us the market generally expects AMETEK to beat and prices the outcome in quickly, leaving little sustained directional drift.

The most recent four quarters illustrate the pattern. On August 4, 2026, AMETEK reported EPS of $2.09 against an estimate of $1.99, a 5.0% surprise; the stock rose 0.28% the next day and 0.89% over the following five sessions. On April 30, 2026, EPS of $1.97 beat the $1.90 estimate by 3.7%, but the stock fell 2.13% the next day and 0.33% over five days. On February 3, 2026, EPS of $2.01 beat the $1.94 estimate by 3.6%, with the stock down 0.48% the next day but up 1.83% over the next five sessions. On October 30, 2025, EPS of $1.89 beat the $1.76 estimate by 7.4%, producing a 1.91% next-day gain but a 0.54% decline over the following five trading days.

Heading into the November 3, 2026 report, the consensus EPS estimate is $2.11. The historical beat rate and the flat average drift suggest investors have learned to expect outperformance, which can make the post-earnings price reaction a function of how much AMETEK beats by and what forward guidance implies, rather than a simple beat-or-miss binary. For a deeper dive into how analysts and institutions are currently modeling revenue, margins and capital deployment, review the full institutional verdict on the name.